MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
ANI Pharmaceuticals, Inc.

ANIP

#1861
ANI Pharmaceuticals, Inc.
73.9000
-2.95%
Sector:
Base:
Profit Currency:
Daily Range
73.9000
73.9000
Year Range
73.8000
96.5699
Daily Change
-2.95%
Monthly Change
-7.56%
6 month change
-21.91%
Year Change
-21.91%
Previous Close
76.1450
Open
73.9000
Bid
Ask
Low
73.9000
High
73.9000
Volume
73
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ANIP
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Zacks Zacks
ANIP RCKT RCUS CSTL
yesterday, 17:46
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
Zacks Zacks
PBYI ANIP CSTL
yesterday, 17:35
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
Zacks Zacks
TGTX ANIP RCUS CSTL
yesterday, 17:08
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
Zacks Zacks
PRGO ANIP CSTL
yesterday, 17:06
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View
Investing Investing
ANIP
yesterday, 14:34
ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth
Investing Investing
ANIP
yesterday, 12:29
ANI Pharma earnings beat by $0.36, revenue topped estimates
Benzinga Benzinga
ANIP
yesterday, 09:46
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - ANI Pharmaceuticals (NASDAQ:ANIP)
Investing Investing
CRI CLMT ESCA AMRX HE
2 days ago, 19:00
Brightspring Health Services, BASF, Swiss Re and more set to report Friday
Zacks Zacks
ANIP ALLO CSTL VTRS
2 days ago, 16:44
Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up
Investing Investing
ANIP
2 days ago, 16:09
ANI Pharmaceuticals set to report earnings as Cortrophin drives shift
Zacks Zacks
ANIP ADMA ALLO CSTL
2 days ago, 15:54
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Zacks Zacks
ANIP CSTL
2 days ago, 14:21
Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd